The Hearing Implant Company

As the industry’s technology leader in implantable hearing solutions, MED-EL products are the result of 30 years of focused research and a commitment by its founders to fostering a company culture of excellence.

MED-EL has a strong tradition of advancing the technological and scientific foundation in the field of hearing implants. The company’s strong and consistent focus on research and development will continue to fuel the pipeline of new ideas and innovations. Our broad portfolio of products ensures that we can provide a hearing implant solution to fit each candidate’s unique hearing loss.

MED-EL was there at the beginning and they will be there for you today, tomorrow and in the future offering state-of-the-art hearing implant solutions that are comfortable to wear and easy to use.

Founders Dr. Ingeborg Hochmair and Prof. Erwin Hochmair at MED-EL international headquarters in Innsbruck.

World's Firsts

  • 1977 Implantation of the world’s first hybrid multi-channel cochlear implant in Vienna.
  • 1991 MED‑EL launches the world’s first BTE (behind-the-ear) speech processor.
  • 1994 Introduction of the COMBI 40, the world’s first multi-channel high-rate cochlear implant.
  • 1996 Introduction of the COMBI 40+, the thinnest cochlear implant available.
  • 1997 The COMBI 40+ Split Electrode (GB) is introduced for cases of cochlear ossification.
  • 1999 Launch of the TEMPO+ behind-the-ear (BTE) speech processor.
  • 2003 Acquisition of the Vibrant Soundbridge®, the first implantable middle ear hearing device for moderate-to-severe sensorineural hearing loss.
  • 2004 MED‑EL launches the PULSAR cochlear implant, providing future-ready electronics in a ceramic housing.
  • 2005 Introduction of the MED‑EL DUET EAS™ Speech Processor in Europe, the first hearing implant system worldwide to integrate cochlear implant audio processing and acoustic amplification in one compact device.
  • 2006 Launch of the OPUS processors. The SONATA cochlear implant, with small titanium housing.
  • 2007 Launch of EAS*, the ideal solution for partial deafness and the Vibrant Soundbridge® for conductive and mixed hearing losses* in Europe. Launch of the DaCapo rechargeable battery system.
  • 2008 The new MAESTRO™ 3.0 system software means that OPUS processors are now also available for COMBI 40+ implant users.
  • 2009 EAS in the 2nd generation. European launch of the DUET 2 Audio Processor.
 Amadé, the new audio processor of the Vibrant Soundbridge is introduced in Europe.
MED-EL Corporation has established a Comprehensive Compliance Program to assist employees in complying with applicable laws and regulations, a Code of Conduct, and relevant Company Policies and Procedures. The Comprehensive Compliance Program and policies are modified, as necessary, based on changes in laws and regulations. Members of the public wishing to request copies of this document or a copy of the certification required by California Health & Safety Code §119400 may call toll-free, 1-888-633-3524.
*CAUTION - Investigational Device, limited by Federal (or United States) law to investigational use in the USA

© 2013 MED-EL